A $200 million transaction between owner Serán Bioscience and Bain Capital Life Sciences in 2024 helped support the buildout ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback